NEW Report - Tribal Law & Policy: Alzheimer's Disease and Related

IA2 and Splaine Consulting have created policy report for American Indian and Alaska Native Alzheimer's Disease and Related Dementia Issues

CDC: Subjective cognitive decline more prevalent in underrepresented populations

Alzheimer's Drug Discovery Foundation backs new diagnostic biomarker test - Medical Device Network

Journal of the American Geriatrics Society: Vol 70, No 6

What's the new Alzheimer's drug, Donanemab, all about? Can it be a turning point?

Alzheimer's Disease: Some trials to watch over the next year

Study finds visions of nonphysical world are common among cognitively healthy Ojibwe individuals

LTSS Newsletter

Exploring the Multitarget Activity of Wedelolactone against Alzheimer's Disease: Insights from In Silico Study

Dementia Man: An Existential Journey, Theater

Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study - The Lancet Neurology

Public Health Reports in 2022: Impact Factor Increase; COVID-19 Coverage; Authorship by State, Tribal, Local, and Territorial Agencies; and New Department on Public Health Ethics - Andrey Kuzmichev, Noelle M. Harada, Christine